CIAS
NVCR icon

Capital Investment Advisory Services’s NovoCure NVCR Stock Holding History

Capital Investment Advisory Services’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,011
Closed -$224K – 795
2021
Q2 		$224K Buy
+1,011
New +$197K 0.03% 431

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Investment Advisory Services's NVCR Position: Q3 2021 in Review

Capital Investment Advisory Services sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,011 shares — an estimated $224K sold.

Capital Investment Advisory Services first reported a position in NVCR in Q2 2021 and held it in 1 quarter. The position peaked at $224K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Capital Investment Advisory Services reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1,011 NovoCure shares in Q3 2021, an estimated $224K.
  • Capital Investment Advisory Services first reported a position in NovoCure in Q2 2021 and held it in 1 quarter.
  • Capital Investment Advisory Services's NovoCure position peaked at $224K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Capital Investment Advisory Services's 13F filing for Q3 2021, filed 28 Oct 2021.